Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAP21 Inhibitors

PAP21 inhibitors are a class of chemical compounds that target and modulate the activity of the enzyme PAP21, which is involved in post-transcriptional RNA processing. PAP21, or Poly(A) polymerase 21, plays a crucial role in the addition of polyadenylate (poly(A)) tails to the 3' end of mRNA molecules during the final stages of RNA synthesis. This polyadenylation process is essential for the stability, nuclear export, and translation of mRNA, as well as for the regulation of gene expression. By inhibiting PAP21, these compounds can disrupt the normal processing of mRNA, thereby affecting the stability and availability of mRNA molecules for protein synthesis.

The mechanism of PAP21 inhibitors involves binding to the active site of the enzyme, preventing it from catalyzing the addition of the poly(A) tail to nascent mRNA transcripts. This inhibition can lead to alterations in mRNA maturation, affecting the gene expression profile within cells. Researchers use PAP21 inhibitors as tools to study the broader effects of polyadenylation on mRNA metabolism, cellular function, and gene regulation. By blocking PAP21 activity, scientists can explore the intricate relationship between RNA processing and the control of protein synthesis, gaining insights into how cells maintain the balance of gene expression. These inhibitors also provide a means to investigate how dysregulation in mRNA polyadenylation impacts cellular processes such as differentiation, growth, and response to environmental signals, highlighting the importance of PAP21 in the overall control of gene expression.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K, potentially affecting proteins regulated by the PI3K/Akt pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Inhibits MEK, which may alter the MAPK/ERK pathway that can modulate various proteins.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, potentially affecting proteins involved in the stress-activated MAPK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which may impact proteins that are regulated by the JNK signaling pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK1/2, potentially affecting proteins downstream of the ERK pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, potentially affecting proteins involved in the mTOR signaling pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibits PI3K, potentially affecting proteins regulated by the PI3K/Akt pathway.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$199.00
$460.00
$1479.00
1
(0)

Inhibits Gs-alpha subunit, potentially affecting proteins regulated by G-protein signaling.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Inhibits myosin light chain kinase, potentially affecting proteins associated with cytoskeletal regulation.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

Chelates intracellular calcium, potentially affecting proteins regulated by calcium signaling.